![](/img/cover-not-exists.png)
Pharmacology of BMN 250 administered via intracerebroventricular infusion once every 2 weeks for twenty-six weeks or longer in a canine model of mucopolysaccharidosis type IIIB
Matthew Ellinwood, N., Valentine, Bethann, Hess, Andrew S., Jens, Jackie K., Snella, Elizabeth M., Ware, Wendy A., Hostetter, Shannon J., Ben-Shlomo, Gil, Jeffery, Nicholas, Safayi, Sina, Smith, JodiVolume:
123
Journal:
Molecular Genetics and Metabolism
DOI:
10.1016/j.ymgme.2017.12.091
Date:
February, 2018
File:
PDF, 57 KB
2018